Covid-19 News and Discussions


COVID outbreak forces Sault hospital to impose visitor restrictions​

Author of the article:
Kyle Darbyson
Published May 08, 2024 • Last updated 1 day ago • 1 minute read

Join the conversation

Photo to accompany SAH COVID outbreak story
The exterior of Sault Area Hospital, located at 750 Great Northern Road. (File)

Article content​

Sault Area Hospital officials have implemented strict visitor restrictions on its 1B inpatient unit due to a COVID-19 outbreak.

Advertisement 2

STORY CONTINUES BELOW


Article content





Union leaders pledge support for U of T anti-Israel encampment, urge 'consequences' for…​

Close sticky video

Union leaders pledge support for U of T anti-Israel encampment, urge 'consequences' for…






Trackerdslogo
Starting Wednesday, only one essential caregiver will be allowed to visit a patient in this unit between 8:30 a.m. and 8:30 p.m., according to a news release from the hospital.

Start the conversation

Have your sayLeave a comment and share your thoughts with our community.
Be the First to Comment
Article content


All other visitors will not be allowed into this unit at this time.



Additionally, all essential caregivers must adhere to the personal protective equipment guidelines directed by staff.



“Anyone who demonstrates disruptive behaviour will be limited in their ability to visit,” read Wednesday’s release.



An essential caregiver is an individual chosen by the patient, or their substitute decision-maker, to support them during their hospital stay.



The essential caregiver assists the patient’s daily care by providing comfort, social and cultural interaction, emotional and physical support, while also speaking on behalf of the patient when they cannot speak.

Advertisement 3

STORY CONTINUES BELOW

7415437498406958448

Article content


Last Friday, Sault Area Hospital 3A, 3B and 3C inpatient units implemented visitor restrictions due to an outbreak of vancomycin-resistant enterococci (VRE) and the heightened risk of patient infection.



East of Sault Ste. Marie, COVID-19 was recently confirmed on the acute care unit of the North Shore Health Network (NSHN), prompting Algoma Public Health to declare an outbreak at the Blind River site.
 

Dr. Roach: Breaking down the causes and symptoms of ‘long COVID’​

Dr. Keith Roach
To Your Health

View Comments
Dear Dr. Roach: I read last year that nearly 20 million Americans were living with long COVID, but I understand that the number is much higher now. Can you explain exactly what long COVID is and how it is treated?
— J.S.B.
Dear J.S.B.: Persistent symptoms after an infection are not unique to COVID. Many people will have cough or asthma exacerbations for weeks or even months after a bad flu infection.
Likewise, many people have symptoms (relating to many different body systems) after recovering from COVID. The Centers for Disease Control and Prevention and the World Health Organization differ on the amount of time after an infection that has to pass for it to be considered “long COVID” — four weeks and three months, respectively.
Dr. Keith Roach


The most common physical symptoms of long COVID are fatigue, shortness of breath and muscle aches. In one study of people who survived the initial wave of COVID, 45% had at least one persistent physical symptom.
The most common and persistent neurological/psychological symptoms are anxiety, depression, post-traumatic stress disorder and cognition problems (“brain fog”). Up to 25% of COVID survivors had one of these symptoms after their physical recovery. This was higher than other respiratory viruses, such as influenza.

For those who required a stay in the intensive care unit, over 75% had physical, psychological or cognitive symptoms after their discharge. These survivors are at the highest risk for prolonged and severe long-COVID symptoms.
There are many hypotheses for the underlying cause of long COVID symptoms, and although there is some evidence, it’s not clear whether there is one single cause or whether multiple mechanisms are possible.

I wish I could get better results from the available treatments. Essentially, we treat each patient’s concerns the same way we would if the person hadn’t had COVID. Emphasis on sleep, nutrition and exercise are critical. But we should still recognize that many people with long COVID have symptoms that are very similar to myalgic encephalomyelitis/chronic fatigue syndrome. As such, exercise should not be overdone, since this can worsen post-exertional symptoms.
Dear Dr. Roach: Do MRI tests, especially of the head, contribute to hearing loss even when earplugs are used?
— M.D.
Dear M.D.: MRI scans are very loud, and exposure to loud noises can cause hearing loss. However, it’s the prolonged and repeated exposure to loud noises that is most likely to cause hearing damage, so MRI scans are not likely to be a problem. Earplugs are still a good idea, though.

There is nothing about the strong magnetic field in an MRI machine that adversely affects hearing. They just make a lot of noise due to the moving electrical coils. Some machines can cause levels up to 110 decibles — as loud as a rock concert.
New MRI technology is coming that will dramatically reduce the amount of noise made during a scan.
 

Was COVID Vaccine Recalled Over Health Danger Fears? What We Know​

Published May 09, 2024 at 8:26 AM EDTUpdated May 09, 2024 at 9:12 AM EDT


01:00
COVID's Evolution May Have Been Driven By Human Behavior, Say Biologists
By Alia Shoaib
Freelance News Reporter
FOLLOW
1

Pharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just months after it admitted it could cause a rare side effect.
The news sparked speculation on social media that the vaccine was being withdrawn because of concerns about associated health risks.

Read more: Compare Top Health Savings Accounts
However, the British-Swedish company said that the decision was made purely for commercial reasons after a decline in demand because of a "surplus of available updated vaccines."

ADVERTISING

"As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines. This has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied," the company said in a statement, according to The Telegraph, which first reported the news. AstraZeneca changed the name of its COVID vaccine to Vaxzevria in 2021.
AstraZeneca Covid-19 vaccines

A stock image shows AstraZeneca COVID-19 vaccines. The company has initiated a global withdrawal of its COVID-19 vaccine. JUSTIN TALLIS/AFP VIA GETTY IMAGES

Sign up for Newsletter
NEWSLETTER
The Bulletin
Your Morning Starts Here
Begin your day with a curated outlook of top news around the world and why it matters.
I want to receive special offers and promotions from Newsweek
By clicking on SIGN ME UP, you agree to Newsweek's Terms of Use & Privacy Policy.You may unsubscribe at any time.
Despite media reports and social media speculation, AstraZeneca has withdrawn the vaccine, but not recalled it.
A recall, which would mean the medication was removed from shelves, typically takes place when there are safety concerns, defects, or regulatory issues posing risks to public health. A withdrawal means that the vaccine is no longer being actively manufactured or supplied by the company.

voices_promo_link.svg
Exclusively Available to SubscribersTry it now for $1
AstraZeneca noted that independent estimates say that over 6.5 million lives were saved in the first year of the vaccine's use and that over three billion doses were supplied globally.
READ MORE Astrazeneca
The company said it had withdrawn its marketing authorizations for the vaccine in the European Union on March 5, which came into effect on May 7.

AstraZeneca will make similar applications in the coming months in the U.K. and other countries that had approved the use of the vaccine, the Telegraph reported. The vaccine was never approved for use in the United States.
Other countries have already stopped using the vaccine; it has not been available in Australia since March 2023.
Newsweek reached out to AstraZeneca for comment via email.

ADVERTISING

The withdrawal comes as the company faces a class-action lawsuit in the U.K. over allegations of side effects associated with the vaccine.

The company is contesting the claims, but admitted in a February legal document that its COVID vaccine "can, in very rare cases, cause TTS," according to the Telegraph.
TTS, or Thrombosis with Thrombocytopenia Syndrome, is a rare side effect linked to certain COVID-19 vaccines, which can manifest in the form of blood clots and a low blood platelet count.
The AstraZeneca COVID-19 vaccine was the first to be rolled out in the U.K. in early 2021.
However, the government reduced its use of the vaccine after emerging reports about the rare risk of blood clots and replaced it with Pfizer and Moderna vaccines.

Sarah Moore, a partner at law firm Leigh Day, which is bringing the legal claims against AstraZeneca, said that the withdrawal will come as welcome news to those who have suffered side effects.
"It will be seen as a decision linked with AstraZeneca's recent admission that the vaccine can cause TTS, and the fact that regulators across the world suspended or stopped usage of the vaccine following concerns regarding TTS," she told the Telegraph.
"This is an important regulatory step, but still our clients remain without fair compensation," she said. "We will continue to fight for the compensation our clients need and campaign for reform of the vaccine damage payment scheme."
Professor Catherine Bennett, the chair of epidemiology at Deakin University in Australia, told The Guardian that it was important to note that the vaccine played a crucial role in the early days of the pandemic.

"It has saved millions of lives and that should not be forgotten," she said. "It was a really important part of the initial global response. However, it targeted the initial ancestral variants. We've now moved into a vaccine chain where we have products available that are chasing the variants that are emerging."
 

‘Vernon is home for us’: COVID-19 pandemic changes course of Nigerian man’s life​

Sydney_Morton.jpg

By Sydney Morton Global News
Posted May 9, 2024 9:11 pm
Updated May 9, 2024 10:41 pm
3 min read
Folu Oloyede with his students at Maven Lane in Vernon, B.C.
View image in full screen
Folu Oloyede with his students at Maven Lane in Vernon, B.C. Dan Couch / Global News
LEAVE A COMMENTSHARE THIS ITEM ON FACEBOOKSHARE THIS ITEM ON TWITTERSEND THIS PAGE TO SOMEONE VIA EMAILSEE MORE SHARING OPTIONS

DESCREASE ARTICLE FONT SIZE
INCREASE ARTICLE FONT SIZE
For all of us, the COVID-19 pandemic was a curve ball we didn’t see coming, but for Folu Oloyede, it changed the course of his life.

70c8fc80

The Nigerian man was visiting his sister in Fort McMurray, Alta., and was scheduled to fly home in April 2020. But when the pandemic hit, Canadian borders closed and planes were grounded, leaving him with no choice but to stay in Canada away from his wife, Kenny, and young son Dotun.
“I couldn’t get a ticket out of Canada and then I was stuck. I tried everything I could because I left a four-year-old baby at home, so I tried to get out of here, but I couldn’t and then I was stuck,” said Oloyede.
During the lockdown, Oloyede stayed with his sister and her family. In August 2020 the Canadian government opened a new temporary policy that allowed visitors to apply for a work permit without having to leave the country. This meant Oloyede could find work; he was able to gain employment from a family in Fort McMurray to help their children with their online schooling.
STORY CONTINUES BELOW ADVERTISEMENT

About a year later, his sister’s husband took a job at the University of British Columbia Okanagan campus in Kelowna, B.C., and asked if Oloyede would like to move to the Okanagan Valley with them.
The daily email you need for Toronto's top news stories.
He took them up on the offer.
He applied for a job at the early childhood education centre, Maven Lane in Vernon, B.C. There, he was referred to the Rural Northern Immigration Pilot Program (RNIP) in 2021 to help put him on the path to gain permanent residency.
MORE ON LIFESTYLE
The RNIP was established in 2020 to create a new immigration path for skilled professionals. The team at Maven Lane helped Oloyede enroll in the program, which works with local businesses and their employees to help streamline the immigration process.
“Permanent residency can take a long time. Our program can still take a long time but there are definitely benefits to it,” said Ward Mercer. regional coordinator of RNIP.
“When we first started, our permanent resident process could be 10 months, whereas others are a lot longer and our work permits are really, really fast.”
However, the program is coming to a close and Mercer says they are no longer accepting applicants. The reason for the pilot closing is that it has reached its five-year maximum and Mercer predicts a similar pilot project will replace it in the near future.
STORY CONTINUES BELOW ADVERTISEMENT

Immigration, Refugees and Citizenship Canada has announced they are in the process of creating a permanent version of the program.
Related News
Since 2020, the pilot has supported 483 businesses and has helped 1,882 new immigrants, including their family members.
“I am blessed and I am happy with the role that Maven Lane took and everything that people talk to me, I just direct the attention back to them because they are the biggest support apart from my sister and her family here. They were solidly behind me,” said Oloyede.
Maven Lane has been working with the RNIP for years, and Oloyede is the fifth teacher of theirs to go through the program and achieve a permanent residency.
“It’s really been important for us as a child-care centre,” said Kyla Macaulay, Maven Lane employee engagement coordinator.
“These children are learning all about the world from us. We are not a school so we don’t need to teach them their ABCs, 1-2-3s, our job is to remind them what fabulous humans they can be.”
Three of the 1,882 people RNIP has helped are Oloyede, his wife, Kenny and their son Dotun. His family arrived in Canada days after he became a permanent resident in 2022.
Now the family lives together in Vernon and they have even added a new addition to the family — three-month-old Tiwa.
STORY CONTINUES BELOW ADVERTISEMENT

“This is home for us now, Vernon is home for us,” said Oloyede.
Oloyede says this is just the start of what he hopes will be along and happy lives here in the Okanagan.
 

Janet Hanlin

Admin
Top contributor
· oSospnedtrm0119u10mugf26fa5i8fua5ug1ifa7l7uiih170h162hti05ah ·

Weekly Ontario Update for Friday, May 3, 2024:

Public Health Ontario has further reduced the amount of data available to the public. In addition, Health Canada has stopped reporting hospitalization data as some provinces are no longer tracking COVID hospitalizations. Unless indicated otherwise, information in this update includes data from Sunday, April 21 to Saturday, April 27, so data is delayed.

Data relating to deaths is even further delayed as cause of death is taking MONTHS to be determined. So recent deaths are far WORSE that are reported.

  • Recent cases: 752 (+ 105 compared to last week)
    Estimates suggest that the actual number of new cases could be more than 10 times higher than what is being reported due to limited eligibility for testing!
  • Weekly positivity rate: 6.3% (+ 0.7% since last week)
  • Recent deaths: 7 (4 fewer than last week)
    - Total deaths are no longer being reported

    Recent deaths are a lagging indicator of the current level of new cases. Deaths are underreported because they are based on date of death and by the time the cause of death is reported, it is no longer considered recent!
  • Average daily hospital bed occupancy: 258* (- 10 since last week week).
    *Please interpret the COVID-19 hospitalization data with caution as not all centers are reporting.
    .
Full list of those eligible for testing can be found here (updated): https://www.ontario.ca/.../covid-19-testing-and-treatment...
Sources: Total cases, total deaths, testing levels and wastewater levels: https://www.publichealthontario.ca/.../Respiratory-Virus...
Some additional COVID stats and info: https://twitter.com/MoriartyLab
 

Weekly case numbers from around Australia: 7,337 new cases (🔺6% see note)​

Australia: Case Update

Accounting for the data adjustments noted last week, both the ACT and WA are seeing double digit increases in cases this week, and nationally cases have increased 23% for the second week in a row.
  • NSW 2,611 new cases (🔺41%)
  • VIC 1,392 new cases (🔺20%)
  • QLD 1,192 new cases (🔺20%)
  • WA 492 new cases
  • SA 1,406 new cases (🔺15%)
  • TAS 103 new cases (🔺32%)
  • ACT 73 new cases
  • NT 68 new cases (🔺13%)
Notes:
  • Case data is from NNDSS Dashboard that is automated from CovidLive
  • These case numbers are only an indicator for the current trends as most cases are unreported.
  • Multiply by 20 or 30 to get a better indication of actual community case numbers.
  • Only SA still collect or report RAT results.
Since case numbers never fully dropped after our summer wave, these last two weeks of high growth have seen cases numbers quickly returning back towards our summer highs (~10K). We are maybe two to three weeks away from reaching the same peak levels based on the current projections.
FluTracker has reported respiratory illnesses activity of 1.7% (🔺0.2% this week) that is higher than the levels seen over summer. In saying that, these levels are currently inline with the expected seasonal increase in respiratory illnesses for this time of year.
r/CoronavirusDownunder - Weekly case numbers from around Australia: 7,337 new cases (🔺6% see note)
Cases have just started to increase in NZ and these appear to be driven by a similar combo of variants as Australia. So a screengrab of their wastewater surveillance that nicely visualise these trends with these new sub-variants. All three variants are all FLiRT variants.
r/CoronavirusDownunder - Weekly case numbers from around Australia: 7,337 new cases (🔺6% see note)
The media have been referring to these as the FLiRT variant (singular), but this term is actually used to describe a soup of multiple JN lineages that have converged to obtain the same two mutations. Most of these other FLiRT lineages haven't taken off.
To mentally visualise the relationship, you could consider KP.* (JN.1.11.1.*) as a great-grandchildren of JN and JN.1.16 is a great-uncle to KP. The KP.2 lineage was first detected internationally on 2 Jan 2024 and KP.3 on 11 Feb 2024.
There is no indication that these variants will be more or less severe than the other Omicron strains. Since these only have minor variations to other variants seen recently, one would assume they'll be on par.
 

COVID-19: Current cases​

Read the latest information about confirmed and probable cases of COVID-19 in New Zealand.
This data is updated weekly. All data on this page relates to cases recorded prior to 11:59 pm 5 May 2024.
Whatu Tāniko pattern

On this page​

Last updated 2pm 6 May 2024.
This data is updated weekly. All data on this page relates to cases recorded prior to 11:59 pm 5 May 2024.

COVID-19 cases summary​

New case average* RATs uploaded average*
327 ↓ 485 ↑
Cases in hospital as at midnight SundayCases in ICU as at midnight Sunday
116 0
Deaths attributed to COVID*Total deaths attributed COVID
3 ↑ 3,995
* 7 day rolling average
** Not currently available

Current situation​

Summary
In the last weekNew cases reported2287
Reinfections1379
Reinfections (< 90 days)14
Total since first New Zealand caseCases reported2634126
Reinfections362765
Reinfections (< 90 days)26405

Case outcomes since first New Zealand case

COVID-19 casesChange in the last weekTotal
Recovered23222627845
Deceased*193995*
*The Ministry of Health has recently switched its definition of 'deceased' from deaths within 28 days of testing positive for COVID-19 to deaths attributed to COVID-19. See the definitions section below for further details.

Deaths with COVID-19​

Cause of deathDied within 28 days of positive testDied more than 28 days after positive testTotalChange in the last week
COVID as underlying2380126250611
COVID as contributory138010914898
COVID-attributed total3760235399519
Not COVID18240*182411
Not available23502353
Total5819235605433*
*The change in total deaths with COVID may not be equal to the number of new deaths reported today. This is because deaths that occurred more than 28 days after a positive test that are subsequently determined to be unrelated to COVID are removed from the total.
Of the 29 people whose deaths we are reporting today: six were from Auckland region, three were from Waikato, one was from Taranaki, one was from MidCentral, six were from Wellington region, two were from Nelson Marlborough, four were from Canterbury, five were from Southern, one was unknown.
Two were in their 60s, five were in their 70s, 14 were in their 80s and eight were aged over 90. Of these people, ten were women and 19 were men.

Case details​

Number of active cases
Change in the last weekTotal since first NZ case
Confirmed23532589531
Probable-6644595
Total2287*2634126
*The change in total case numbers may not be equal to the number of new cases reported today due to data updating and reconciliation.

Definitions​

Active case - confirmedConfirmed cases are people who have received a positive PCR test OR someone who has received a positive result on a Rapid Antigen Test. For more details, see the COVID-19 case definition.
Active case - probableA probable case is when someone is diagnosed based on their exposure to other people with COVID-19 and on their symptoms.
ReinfectionsReinfections are cases in an individual who reported a case 29 or more days previously.
RecoveredRecovered cases are people who had the virus, where at least 7 days have passed since their symptoms started and they have not had symptoms for 72 hours, and they have been cleared by the health professional responsible for their monitoring.
DeceasedIncludes all deaths where COVID-19 is determined to have been the underlying cause of death or a contributory cause of death.

Cases reported each day​

Daily confirmed and probable cases​

New COVID-19 cases reported each day

This graph shows the count of all cases of COVID-19 every day (all cases – confirmed and probable) since the first New Zealand case in late February 2020. The graph shows the rapid increase of daily cases from mid-February 2022 to early March 2022, driven by the Omicron variant.
From mid-March to mid-April 2022, cases rapidly declined, followed by a period of slower decline until early July. This was followed by a rapid increase in cases, peaking in August before a steady decline in new daily cases. Reported new daily cases hit their lowest since February 2022 in September 2022.
New COVID-19 cases reported each day
This graph shows the count of all cases of COVID-19 every day (all cases – confirmed and probable) since the first New Zealand case in late February 2020. The graph shows the rapid increase of daily cases from mid-February 2022 to early March 2022, driven by the Omicron variant. From mid-March to mid-April 2022, cases rapidly declined, followed by a period of slower decline until early July. This was followed by a rapid increase in cases, peaking in August before a steady decline in new daily cases. Reported new daily cases hit their lowest since February 2022 in September 2022.

COVID-19 by location​

Total cases by location​

Total COVID-19 cases by location graph

This bar graph shows the total cases and their status by health district and those with recent travel history.
The ‘At the border’ data group includes cases detected in managed isolation or quarantine facilities from the period when these were operating, as well as cases with recent travel history from after that time. They are not included in the district totals. Before 17 June, people in managed isolation or quarantine facilities were included in the total of the relevant district.
Total COVID-19 cases by location graph
This bar graph shows the total cases and their status by health district and those with recent travel history.
The ‘At the border’ data group includes cases detected in managed isolation or quarantine facilities from the period when these were operating, as well as cases with recent travel history from after that time. They are not included in the district totals. Before 17 June, people in managed isolation or quarantine facilities were included in the total of the relevant district.

Total cases by location​

LocationActiveRecoveredDeceasedTotalNew cases in the last week
Auckland193247245269247707194
Bay of Plenty105115648186115939105
Canterbury310348356555349221311
Capital and Coast182186592184186958181
Counties Manukau179294005321294505179
Hawke's Bay67864091688664466
Hutt Valley105911899991393105
Lakes30515861115172730
Mid Central1289721620797551128
Nelson Marlborough96801641598041996
Northland91816121498185291
South Canterbury2834886443495828
Southern147193411382193940147
Tairāwhiti1326718442677513
Taranaki72660741296627572
Unknown42284922974
Waikato174209503399210076175
Wairarapa4625807652591846
Waitematā277311289409311975277
West Coast1115917221595011
Whanganui2834642783474828
At the Border*027292627298NA
Total22862627845399526341262287
* Due to retiring the COVID-19 Protection Framework on 12 September 2022, the Ministry of Health no longer separately reports COVID-19 cases who have recently travelled overseas. These cases will be included in the weekly reporting on all COVID-19 community cases, but we will no longer distinguish between border and other cases.
You can also view a detailed breakdown of daily case numbers for each district since the beginning of the pandemic by clicking the ‘download’ button on the right hand side of this page: New Zealand COVID-19 data.

Note: we cannot give detailed information about cases in your district, city or town, as we must protect the privacy of the people concerned.

Also in this section​

Last updated: 7 May 2024
 

‘FLiRT’ COVID-19 subvariant dominant in Canada. What to know about the strain​

katie_dangerfield_220x260px.jpg

By Katie Dangerfield Global News
Posted May 10, 2024 6:00 am
Updated May 10, 2024 11:40 am
5 min read


Video will begin after these messages...
close video
RELATED: China froze COVID-19 origin tracing, investigation finds. – Apr 22, 2024
LEAVE A COMMENTSHARE THIS ITEM ON FACEBOOKSHARE THIS ITEM ON TWITTERSEND THIS PAGE TO SOMEONE VIA EMAILSEE MORE SHARING OPTIONS

DESCREASE ARTICLE FONT SIZE
INCREASE ARTICLE FONT SIZE
Canada’s lull in COVID-19 cases faces a potential disruption with the emergence of a new family of subvariants, playfully dubbed the ‘FLiRT’ variants.
70c8fc80

These genetic cousins, originating from JN.1, the Omicron subvariant that fuelled the winter surge, are now spreading nationwide, with one variant, KP.2, quickly gaining dominance in Canada.
KP.2 is the dominant subvariant of the JN.1 strain, explained Gerald Evans, an infectious disease specialist at Queen’s University in Kingston, Ont. As of April 28, national data shows that KP.2 accounted for 26.6 per cent of all COVID-19 cases in Canada, surpassing other JN.1 subvariants.
“The nomenclature KP.2. really throws people for a loop,” Evans told Global News. “But it’s just a continued evolution of what we’ve been seeing for the last bit of time since the beginning of this year, which is the JN.1 lineage.”
STORY CONTINUES BELOW ADVERTISEMENT

Click to play video: 'Health Matters: JN.1 variant now world’s most dominant COVID strain, WHO says'


2:56Health Matters: JN.1 variant now world’s most dominant COVID strain, WHO says
This subvariant, as well as KP.1 and KP.3, make up what is known as the FLiRT variants, Evans said.
“FLiRT is a bit of an odd name, and it’s not like one of these names that’s been given by a social media person,” he said, adding there is scientific meaning behind it.
They are nicknamed FLiRT mutations because the amino phenylalanine (abbreviated as F) replaces the amino acid leucine (abbreviated as L), while the amino acid arginine (R) is replaced by threonine (T), he said.
“And the I is just in there to make it sound like a real word. So that’s what FLiRT stands for. It’s just a designation to talk about where the mutations line,” he said.

What is KP.2?​

On Wednesday, the World Health Organization (WHO) stated that the KP.2 subvariant began circulating globally in January.
STORY CONTINUES BELOW ADVERTISEMENT

“KP.2 is a descendant lineage of JN.1, which is the dominant strain worldwide,” Maria Van Kerkhove, WHO’s technical lead for COVID-19, said during a Wednesday virtual press conference. “KP.2… has additional mutations in the spike protein. There are other emerging variants, and JN.1 continues to evolve we will continue to see these variants circulating.”
The latest health and medical news emailed to you every Sunday.
She added that the WHO continues closely monitoring the virus’s evolution.
In Canada, the emergence of KP.2 was first observed in February. Evans clarified that it’s named “KP.2” because when a variant accumulates more than three numbers in its designation, a new prefix is assigned. In this case, JN.1 turned into KP.2
“It’s because of this funny prefix change that people think, ‘Oh, it’s a whole new variant’,” he said. “It’s just the continued evolution of the viruses.”

Is KP.2 more contagious?​

While COVID-19 levels are currently relatively low on average across Canada, Dr. Isaac Bogoch, an infectious diseases specialist, highlighted the latest mutation suggests it may be more adept at evading our immunity, potentially indicating a looming spike in COVID-19 cases.
STORY CONTINUES BELOW ADVERTISEMENT

“This year we didn’t see much of a spring COVID-19 wave,” Bogoch told Global News. “Could [KP.2] cause an uptick of COVID infections? Sure it could. The mutations might enable the virus to circumvent current immunity and cause reinfection. But typically, on average, the severity of those infections is lower.”
Bogoch said although the FLiRT variants may be able to better evade people’s immunity, we are “still not dealing with an immuno-naive population.”
Click to play video: 'COVID: What we know about JN.1, Canada’s new dominant strain'


6:34COVID: What we know about JN.1, Canada’s new dominant strain
He emphasized that the majority of individuals have either been infected with COVID-19, vaccinated, or both. This implies that the virus poses less of a threat to healthy adults and children. However, he underscored that it remains a significant concern for seniors and immunocompromised individuals.
“People of course can still get infected and reinfected. But the severity of illness is on average much less,” he said.
STORY CONTINUES BELOW ADVERTISEMENT

Evans agreed, noting that although current data indicates the KP.2 subvariant possesses a reproductive advantage, it still has a notably diminished growth rate compared to previous variants.
“It looks like it’s not quite as infectious as the previous generations,” Evans said. “And the most preliminary data from experiments in research labs shows that it’s about a tenfold diminishment in its infectivity. So that’s great because it means it’s less infectious and less likely to potentially infect someone if you come in contact with it to some degree.”

FLiRT COVID symptoms: What are they?​

While acknowledging that the data is still fresh, Bogoch noted that so far, symptoms of the FLiRT variants appear to align closely with those of all Omicron ones.
“We know what the symptoms typically are for COVID-19. It’s unlikely that there’ll be any surprises on that front,” he said.
STORY CONTINUES BELOW ADVERTISEMENT

Symptoms of COVID-19 include:
  • sore throat
  • runny nose
  • sneezing
  • new or worsening cough
  • shortness of breath or difficulty breathing
  • feeling feverish
  • chills
  • fatigue or weakness
  • muscle or body aches
  • new loss of smell or taste
  • headache

Does the current vaccine work against FLiRT variants?​

The COVID-19 vaccine currently accessible in Canada targets the XBB 1.5 Omicron subvariant. Evans clarified that despite its lack of inclusion of the JN.1 virus, it is expected to provide efficacy against the FLiRT variants.
“It is offering some protection against the JN.1,” he said.
Evans emphasized that if you’re young, and in good health, having received your COVID-19 vaccine in the autumn, another booster likely won’t be necessary until fall 2024.
However, for Canadians aged 65 and above, as well as those who are immunocompromised, he advised getting the spring booster.
STORY CONTINUES BELOW ADVERTISEMENT



Click to play video: 'Health Matters: Yale Public Health researchers recommend annual COVID-19 vaccination'


2:54Health Matters: Yale Public Health researchers recommend annual COVID-19 vaccination
Last week, the National Advisory Committee on Immunization (NACI) released its fall 2024 COVID-19 vaccine guidelines, saying it anticipates another surge in the fall and winter months.
“An updated vaccine to replace the current XBB.1.5 vaccine may be available starting in the fall of 2024, depending on the epidemiology of SARS-CoV-2 and recommendations of international advisory groups expected in mid-spring 2024,” NACI noted.
On Wednesday, the WHO said its Technical Advisory Group on COVID-19 Vaccine Composition recommended that future formulations of the shot include JN.1.
“The WHO is deciding on using JN.1 for vaccine manufacturing as the template and we’ll hear from the United States probably next month.,” Bogoch said.
“But if it’s an arms race and we’re trying to stay ahead of the virus, it’s going to be extremely difficult because the virus is going to continue to mutate, very similar to playing catch-up with influenza vaccines and a constantly changing influenza virus.”
 

A new Covid variant has taken over, and experts predict a small summer wave​

The variant, called KP.2, now makes up the largest share of new infections in the U.S.
People, some wearing masks, walk on the boardwalk

Coney Island's boardwalk in Brooklyn in 2021.Nina Westervelt / Bloomberg via Getty Images


May 10, 2024, 5:28 PM EDT
By Aria Bendix
Disease experts anticipate a small uptick in Covid cases this summer, as a new variant spreads.
The KP.2 variant represents 28% of Covid infections in the U.S., up from just 6% in mid-April, according to data released Friday by the Centers for Disease Control and Prevention.

KP.2 became dominant at the end of April — meaning it accounts for the largest share of new cases — outpacing the JN.1 variant, which took over in the winter.
Some scientists collectively refer to KP.2 and another variant called KP.1.1, which shares the same key mutations, as “FLiRT” — a reference to their amino acid changes.
Both are descendants of JN.1, which is part of the omicron lineage, like all versions of the coronavirus that have gained dominance in the last couple of years.
But KP.2 has three additional mutations in its spike protein compared with JN.1, which disease experts said could make it easier for the virus to bypass protection from vaccines or prior infections.
“It looks like those additional mutations make it more immune evasive, so it’s not a surprise that it would then dominate,” said Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center in Boston.
Laboratory research from Japan, which was published as a preprint and has not been peer-reviewed, suggests that the Covid vaccines currently recommended in the U.S. may be less effective against KP.2 than against JN.1.
However, KP.2 might be less efficient at infecting cells, the research suggests, which could mean that a higher dose of the virus would be needed to infect someone.
People who were infected with JN.1 should still have some protection against KP.2, experts said.
The CDC does not collect regular data on how Covid symptoms are evolving over time, so it’s hard to assess whether illnesses caused by KP.2 look any different. Covid symptoms have generally been consistent over the last two-plus years.

Experts predict a small rise in cases this summer

Covid cases have spiked every summer in the U.S. since 2020. If KP.2 continues to gain prevalence, that pattern may repeat — but not as dramatically, experts predict.
The U.S. is in a good place with Covid heading into the summer, according to Andrew Pekosz, a virologist at Johns Hopkins University. Hospitalizations reached record lows at the end of April, the last data available before the CDC stopped requiring hospitals to report Covid admissions numbers.
“We see a late summer, early fall surge of cases, and then we see a second surge of cases right around the Christmas holidays, the New Year,” Pekosz said. “That pattern has been sort of reproducing itself for a couple of years now. The important thing, though, is the magnitude of the cases has been consistently dropping.”

Several factors could help the KP.2 variant spread this summer. When the weather gets very warm, people tend to congregate indoors to escape the heat, creating new opportunities for transmission. Many people also haven’t been vaccinated recently; less than a quarter of U.S. adults have received the updated Covid shot.
“I think that there’s going to be a significantly large susceptible population out there, from that combination of waning immunity and viral evolution, that we’re going to see a number of cases this summer,” said Dr. Thomas Russo, chief of infectious diseases at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences.
But he added that since most people have some immunity to Covid, it’s possible that “the wave won’t be as great” as in previous years.
Barouch said past summer waves have coincided with the arrival of new variants, so this year could be similar.
“The increases in the summertime have often been in the context of new variants, such as the original Delta wave, for example, or the BA.5 wave,” he said. “So I wouldn’t be surprised if there is another summertime surge.”

Will KP.2 affect vaccine recommendations?​

KP.2’s rise creates questions for the public health experts who decide which variants to target with new Covid vaccines.
The Food and Drug Administration on Tuesday postponed an advisory committee meeting that was meant to decide which strains to include in the updated vaccine formula for the fall.
"We have recently observed shifts in the dominant circulating strains of SARS-CoV-2," an FDA spokesperson said. "The additional time will allow the agency to obtain more up-to-date surveillance data and other information on the circulating strains of SARS-CoV-2 to better inform the committee’s discussions and recommendations."
The most recent vaccine-related recommendations from the CDC came in February, when it suggested that people ages 65 and up should get an additional dose and younger people could consider one.
People who haven’t received the updated shot and feel like they need it "should get the vaccine that’s currently available,” Barouch said.
But Pekosz said people who are not immunocompromised could probably hold off until the fall.
“With case numbers being relatively low right now, I think the prudent thing is to try to wait till September and get the new formulation,” he said.
 

"FLiRT" COVID variants are now more than a third of U.S. cases. Scientists share what we know about them so far.

By Alexander Tin
Edited By Paula Cohen
May 10, 2024 / 10:31 AM EDT / CBS News



More than a third of COVID-19 cases in the U.S. are now estimated to be from a new, fast-growing member of a group of so-called "FLiRT" variants, nicknamed for their small but distinctive changes relative to the JN.1 strain. JN.1 was the variant behind this past winter wave of infections.

The largest among them, called KP.2 by scientists, has quickly multiplied in recent weeks to become the now-dominant new COVID-19 strain.

According to the Centers for Disease Control and Prevention's every-other-week variant estimates, KP.2 and another strain with the same FLiRT mutations, called KP.1.1, together make up a projected 35.3% of infections this week. This is up from 7.1% a month ago.

"That means that while KP.2 is proportionally the most predominant variant, it is not causing an increase in infections as transmission of SARS-CoV-2 is low," a CDC spokesperson told CBS News in a statement.

The strain also does not have large amounts of worrying changes, unlike some previously highly-mutated variants that have raised alarm in years past.


However, the swift change in circulating variants has resulted in the Food and Drug Administration this week delaying a key step in its process for picking out the strain to target with this fall's COVID-19 vaccines, citing the need for more "up-to-date" data.

While federal requirements for hospitals to report COVID-19 data to authorities lapsed this month, the CDC says it still has reliable figures from sources like wastewater testing and emergency rooms to continue tracking activity from the virus.

Here's the latest of what we know about COVID-19 variants in the U.S.

What is the current new variant of COVID-19?​

According to the latest projections published by the CDC, around 28.2% of COVID-19 cases nationwide are now being caused by a sublineage of the virus called the KP.2 variant.


The next largest variant on the rise is another JN.1 descendant called JN.1.16. That strain has not grown as quickly, only inching up to an estimated 10% of cases this week.

That projection is based on genetic sequences of the virus reported by mostly public health labs, which have dropped significantly in recent weeks alongside the slowdown in cases overall. Other CDC data from wastewater and traveler testing still does not separate out KP.2 from its JN.1 parent.

KP.2 is a closely related descendant of the JN.1 variant from this past winter, which turned out not to be significantly more severe than the variants that were dominant before it, despite its large number of mutations.

"So it's one that we are watching. It's one that we are monitoring. And again, reiterate the need for continued surveillance of SARS-CoV-2 in people around the world, so that we can monitor this evolution," the World Health Organization's Maria Van Kerkhove told reporters Wednesday.

Why are these COVID-19 variants called FLiRT?​

The nickname FLiRT comes from two distinctive mutations seen in several descendants of the JN.1 variant that have sprung up around the world after its sweep over the winter. Some of the largest strains with FLiRT mutations in the U.S. right now are KP.2 and KP.1.1.

"It is essentially just making a word out of the specific amino acid changes in the spike protein F456L + R346T, or phenylalanine (F) to leucine (L) at position 456 and arginine [R] to threonine [T] at position 346," Canadian biologist Ryan Gregory, a professor at the University of Guelph, told CBS News in an email.

Gregory coined this nickname in March, and it gained traction among the variant trackers who have spotted and nicknamed many distinctive changes to the virus during the pandemic. Though unofficial, these nicknames have become commonly used names for a number of variants.


FLiRT won out over another nickname — "tiLT" variants — which had been coined by Australian consultant Mike Honey. FLiRT refers to a collection of faster-growing JN.1 offshoots the trackers are keeping an eye on, KP.2 among them.

"Basically, pretty much everything right now is a descendant of BA.2.86.1.1 (JN.1) and things are evolving rapidly, so it makes more sense to focus on mutations of interest rather than individual variants for the time being," wrote Gregory.

Do FLiRT variants lead to different COVID-19 symptoms?​

Unlike some previous highly mutated variants that had raised concerns over potential changes to symptoms in recent years, the JN.1 variant many Americans already likely caught over the winter is closely related to the KP.2 strain now on the rise.

"Based on current data there are no indicators that KP.2 would cause more severe illness than other strains," a CDC spokesperson told CBS News.

KP.2's two distinctive so-called FLiRT mutations have also been seen before, in XBB.1.5 variants that were circulating throughout 2023, the spokesperson said.

A draft study from scientists in Japan, released as a preprint that has yet to be peer-reviewed, found that the variant did appear to dodge antibodies better than the JN.1 variant. This "increased immune resistance" likely explains its rise, the scientists said.

In general, health authorities and experts have downplayed claims that variants were causing different symptoms. Changes to a person's immunity from vaccines and prior infections often play a role in different symptoms, rather than specific mutations.


"Mutations happen frequently, but only sometimes change the characteristics of the virus," the CDC says.

Will vaccines work against FLiRT variants?​

The CDC has not made any changes to its current vaccine recommendations, which were last updated in April. But the emergence of these new JN.1 variant descendants like KP.2 might affect what vaccine the FDA picks out for this coming fall and winter.

Most Americans remain eligible to get at least one dose of this past season's updated COVID-19 vaccine, which CDC data so far suggests was up to 51% effective against emergency room or urgent care visits during a time when JN.1 was on the rise.

"CDC will continue to monitor community transmission of the virus and how vaccines perform against this strain," the agency said of KP.2.

Last month, the World Health Organization's experts recommended that vaccine manufacturers produce shots targeted at the JN.1 variant for next season. A panel of the FDA's own vaccine experts were scheduled to weigh that approach for the American vaccine market next week.

However, the agency recently announced it had decided to delay the meeting until June in hopes of buying more time to ensure it picks out a vaccine target that is "most appropriate to be used for the strain(s) anticipated to be circulating" in the fall.

"The FDA, along with its public health partners, carefully monitors trends in the circulating strains of SARS-CoV-2. As has happened since the emergence of COVID-19, we have recently observed shifts in the dominant circulating strains of SARS-CoV-2," an FDA spokesperson told CBS News in a statement.


Pfizer has generated data from research of its vaccines against KP.2, but a company spokesperson said they were currently unable to share the results. A Moderna spokesperson did not respond to a request for comment.

A Novavax spokesperson said they had data showing their vaccine candidate for the fall aimed at JN.1 has "good cross-reactivity" for KP.2. While Novavax's vaccine takes longer to make than the mRNA shots from Pfizer and Moderna, the spokesperson said FDA's delay to the meeting "will not affect" their ability to deliver a shot this fall.

"We have manufactured JN.1 consistent with the recommendations and are on track to deliver an updated vaccine this fall," the Novavax spokesperson said.
 

Covid Update: The Flirt Variants​


 

New COVID variant strains called 'FLiRT': what to know​


 

77% of Japan's COVID-19 oral drugs set to be destroyed: estimate​




KYODO NEWS
KYODO NEWS - 12 hours ago - 13:56 | All, Japan, Coronavirus







The Japanese government is set to destroy 77 percent of the COVID-19 oral medications it purchased during the novel coronavirus pandemic as they remain unused, an estimate based on government data showed Saturday.
Of the oral drugs secured for 5.6 million people, those for 4.3 million people remain unused. The drugmakers have already made the medications available to the public and the government can only provide them in the event of an emergency after the legal status of the disease was downgraded to the same category as seasonal flu in May last year, the health ministry said.
photo_l.jpg

File photo shows Xocova tablets produced by Shionogi & Co. (Photo courtesy of Shionogi & Co.)(Kyodo)
The remaining Xocova tablets produced by Shionogi & Co., Lagevrio capsules made by Merck & Co. and Paxlovid pills manufactured by Pfizer Inc., estimated to be worth 300 billion yen ($1.93 billion), are expected to be destroyed as they expire.
Ataru Igarashi, a specially appointed professor at the University of Tokyo with expertise in pharmacoeconomics, said it is difficult to accurately predict the quantity of drugs required when a situation is evolving.
"A shortage of drugs would put people's health at risk and having too much would result in financial losses. We must debate how much of either case we can tolerate before the next infectious disease emerges," Igarashi said.
photo_l.jpg

File photo shows Lagevrio capsules made by Merck & Co. (Photo courtesy of Merck & Co.)(Kyodo)
Japan secured Xocova for 2 million people, Lagevrio for 1.6 million and Paxlovid for 2 million, according to the Health, Labor and Welfare Ministry. The amount paid for the purchases has not been disclosed.
Calculations using publicly available data on the volumes of purchases and shipments showed that Japan still held Xocova for 1.77 million people, Lagevrio for 780,000 and Paxlovid for 1.75 million as of the end of March. The drugs were priced at 52,000 yen, 94,000 yen and 99,000 yen per person, respectively.
photo_l.jpg

File photo shows Paxlovid pills manufactured by Pfizer Inc. (Photo courtesy of Pfizer Inc.)(Kyodo)
While more than half of the purchased Lagevrio capsules were shipped, fewer than half of the Xocova tablets were as government approval for the drug came relatively late in the pandemic. Paxlovid pills have not been used as much as expected as they cannot be taken with certain drugs.
Japan has already disposed of 240 million shots of COVID-19 vaccines after initially signing contracts for the purchase of 930 million shots and later canceling some. The health ministry has told the Diet the destroyed vaccines were worth 665.3 billion yen.
 

UCP board urges Premier Danielle Smith to make COVID vaccine policy changes for children​

Calgary riding hosting event with high-profile vaccine skeptics​

Jason Markusoff, Joel Dryden · CBC News · Posted: May 11, 2024 2:58 PM EDT | Last Updated: 3 hours ago
Gloved hands draw put a needle into a vial.

Medical practitioners have administered millions of COVID vaccine doses to Albertans, most of them the mRNA shots that are the target of a United Conservative group's upcoming speaker event. (Hannah Beier/Reuters)

Social Sharing​


  • Facebook

  • X

  • Email

  • Reddit

  • LinkedIn
The United Conservative Party's board is urging Premier Danielle Smith to reform COVID vaccine policy because the directors are worried about the safety of mRNA vaccines for kids, the party president says.
"We have serious concerns about them for children," Rob Smith, the UCP president, told CBC News in an interview Friday.
"I would say that the board of directors' position is that if parents are going to get their children vaccinated, they need to be very, very sure that they know what they're doing."


Asked what the change would look like in practice, Rob Smith said it would see AHS "doing a better job of sharing information about the vaccine that they are offering."
He wants AHS to disclose "the science behind the vaccine, and the potential repercussions," as well as the research and the testing methodology behind it.
He said the board has communicated its concerns to the premier, adding "we believe that there will be action coming from the government with respect to AHS's offerings of COVID vaccinations and the ages for which they're recommending."
The party president's comments come as a Calgary wing of the UCP prepares to host a gathering of medical speakers who claim COVID vaccines are dangerous and even deadly, hoping to use that event to help persuade UCP MLAs and Smith to ban mRNA COVID immunizations for children.
Health Minister Adriana LaGrange's office declined to answer questions about this event and the United Conservatives' advocacy for vaccine restrictions.
A cinema-style advertisement for the event

The United Conservative Party's logo is included on a poster for the event that casts doubt on COVID vaccine safety. (Screengrab)
The town hall planned for June is hosted by the UCP riding association for Calgary-Lougheed, a southwest city district, along with its rookie MLA, Eric Bouchard. They are bringing in doctors and researchers from as far away as Texas and Ontario, including two whose medical colleges have sanctioned them for unprofessional conduct and for spreading falsehoods and misleading information about vaccines and COVID public health measures.


The goal of the event is to "persuade the UCP Alberta caucus to declare the moratorium on all COVID mRNA vaccines" for children in the province. That's a move that would set Alberta apart from the rest of Canada.
Currently, Alberta Health's COVID information website says vaccines, including those that use messenger RNA technology, are "safe, effective and save lives," while the World Health Organization recommends doses for children older than six months who are immunocompromised or have higher risk of severe COVID.
The organizers of the event "An Injection of Truth" take a dimmer view. Their advertisements allege the vaccines are likely contributing to an increase in deaths of Alberta minors. "Ask yourself, 'How can we help Albertans put a stop to COVID shots that kill children?'" the ticketing website states.
The president of the section of pediatrics for the Alberta Medical Association finds the claims "saddening" fringe views, informed by hearsay and innuendo.
Sam Wong said he has not read anything in official pediatrics or medical literature that supports views that mRNA vaccines are untested or dangerous for children.
"I can't see any drawbacks to the use of the mRNA vaccination in children or adults," Wong said.

"The broad view of pediatricians across Canada, of the infectious diseases group, is that the mRNA vaccinations are safe and effective."

'All-star' panel​

The event boasts what organizers call an "all-star medical and expert panel."
Among the seven advertised speakers are Chris Shoemaker and Mark Trozzi, two Ontario doctors whose professional college suspended their licences due to allegations they each committed professional misconduct with their statements about COVID vaccinations and health measures.
Shoemaker, whose personal website declares a need to "save the children — end the vaxx," has had his licence suspended and was referred to the College of Physicians and Surgeons of Ontario disciplinary tribunal last year.
The tribunal ordered Trozzi's registration certificate revoked earlier this year, after finding him "incompetent" as well as unprofessional for comments that included "promoting a false narrative about 80 deceased doctors."
Trozzi has appealed that decision, and continues to post about COVID vaccines on social media and his Substack page.

"The greatest medical atrocities in history have been committed; with tens of millions of people killed and hundreds of millions injured," Trozzi wrote on Substack. "My mission is to stop COVID-19 crimes, bring the perpetrators to justice, and advance the treatment of the injured, providing education to recover their health, fertility, and longevity."
Calgary pediatric neurologist Eric Payne is also listed in advertisements for the event. In October 2021, Payne was one of four Alberta doctors who launched a lawsuit against Alberta Health Services' mandatory workplace COVID-19 vaccination policy.
William Makis, another Alberta-based speaker who has raised concerns about the COVID vaccine, is also scheduled to appear.
None of the other speakers coming in are practicing physicians. All are prolific on social media with their claims about vaccine safety.
CBC News reached out to Trozzi, Payne, Shoemaker and Makis for comment.
"I look at all sides but stand comfortably on my educated opinion," Shoemaker wrote in an email response.

In a public response on social media to questions from CBC News, Makis said that he has been asked to speak to dozens of live events as a keynote speaker.
Lawyer Michael Alexander, a representative for Trozzi, said in an email that "Regardless of venue, Dr. Trozzi's goal is to engage others in seeking the truth about medical and scientific issues relating to COVID-19."
"Further, Dr. Trozzi does not ask anyone to 'trust' his views on mRNA genetic injections or anything else. He presents science-based information on his website and people are free to make up their minds about the injections."
CBC News has yet to receive a response from Payne.
In an interview, event organizer Darrell Komick said he's bringing in these speakers because they're the ones investigating and willing to speak about children's deaths and potential vaccine links.
"This isn't a bunch of crazed lunatics looking to be overly provocative," said Komick, president of the Calgary–Lougheed UCP association. "This is just people trying to ask a simple question."

Komick told CBC News that Florida and Japan have already banned mRNA vaccines for children, "based on science." In fact, neither has done so.
Florida's top health official has openly questioned mRNA vaccine safety, but the immunizations remain available. Meanwhile, misinformation about Japan and vaccines has recently circulated on social media.

Adverse events​

The Public Health Agency of Canada has tracked adverse events reported following COVID vaccinations — including pain, headaches and more severe reactions. As of this January, it reported them at a rate of 40 per 100,000 doses for Canadian children four and under, with lower rates for children aged five to 17. Rates are slightly higher for most older age groups.
After more than 100 million COVID vaccinations administered, there have been 488 reports of deaths following vaccination in Canada. Officials assess four of those to be consistent with causal association with immunization. The rest are unlikely to be linked to the vaccine, indeterminate or not classifiable, according to the public health agency.
Dr. Lynora Saxinger, an infectious disease physician at the University of Alberta, said experts are frequently battling against comments made about safety that aren't supported by reputable sources of data.
"There's a lot of things that people attribute to vaccines, but they have to remember that at the moment, 5.5 billion people or more in the world have had a COVID vaccine," she said. "And every single health event that was going to happen in the world, had this never happened in a parallel universe without COVID, is still going to happen."

Also speaking at the event is Shane Getson, a United Conservative MLA from central Alberta. He has stated he was "vaccine injured" following his first COVID immunization in 2021.
Rob Smith, the party's president, advertised this UCP constituency event last week in a monthly email to all party members.
In the regular newsletter, he reported the party's provincial board met with Premier Smith via Zoom in mid-April, and topics included "COVID vaccines for infants and children."
A woman stands by flags, drinking water.

Premier Danielle Smith at a health-care policy announcement last year. One of her first acts as premier was to fire the province's chief medical officer of health, Dr. Deena Hinshaw. Smith had spent months criticizing her pandemic management. (Jason Franson/The Canadian Press)
The newsletter includes a full 778-word promotion for the event, encouraging non-Calgarians to watch via online streaming. It goes on to state: "Our objective is to remove COVID mRNA shots from the AHS childhood vaccination list.
"Please share the word; you are making a difference."
The UCP logo appears on the event's advertising materials. It offers tickets at a discounted price for United Conservative members, and is followed by a $159-a-ticket "politics and popcorn" political fundraiser where attendees can meet with United Conservative MLAs.

"I don't know that we're trying to change UCP policy," Komick said about his event's stated goals about reforming vaccine rules. "We're trying to effect change for kids. That requires AHS to change."
Not only would Alberta be unique among provinces if it restricted COVID vaccines for children or adults, but it would also depart from its own process if the UCP caucus directed such a decision.

COVID vaccination use in Alberta is ultimately determined by the Alberta Health ministry, so could technically be subject to political decisions from the minister, cabinet and UCP caucus.
However, that would be completely out of step with how vaccine decisions have long been made in the province: largely based on Health Canada vaccine approvals and recommendations from the National Advisory Committee on Immunization (NACI), as well as localized input from medical experts on the Alberta Advisory Committee on Immunization.
A man stands behind a podium and a microphone, wearing a suit.

Rob Smith, president of the United Conservative Party, reported last week in a monthly email that the party's provincial board met with Premier Smith via Zoom in mid-April, and topics included 'COVID vaccines for infants and children.' (Facebook)
Premier Danielle Smith rode to popularity within the United Conservative base for her firm stance against COVID vaccine mandates and other public health decisions.

In 2021, before returning to politics, she penned a column that said requiring people to take an mRNA vaccine may fly in the face of a post-World War II convention against forced human experiments.
Smith herself declined to get the widely available Pfizer or Moderna inoculations, choosing instead to fly to Arizona to get a non-mRNA vaccine that wasn't available at the time in Canada. But in her 18 months as premier, her government has placed no restrictions on mRNA vaccination, and continues to administer them to Albertans as young as six months old.
The UCP government has struck a special review of pandemic-era health data, and chose as its leader a doctor who accused the province of exaggerating COVID's impact on hospitals. Two people billed to appear at the June town hall — Payne and Jessica Rose — were initially appointed to that panel, but later withdrew, according to the Globe and Mail.
"There are a couple of concerns that I have about the number of unexplained deaths. I wanted to know what was behind that," the premier said last week about that government panel.
While the event's website and promotional materials do not disclose the venue's site (unless one buys a ticket), CBC News confirmed that the town hall will be held at Southside Victory Church. That church was fined in 2020 for holding services that violated public health rules that limited public gatherings.
 
@Sharma Ji

Thank goodness I didn't take that AZ junk.


AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten​

Robin McKieScience editor
Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives

Sat 11 May 2024 15.29 BST
Share


Last week’s announcement that AstraZeneca would no longer market its Covid vaccine brings an end to one of the century’s most remarkable medical stories. Created within a year of the arrival of the pandemic, the AZ vaccine was cheap, easily stored and transported, and helped stave off humanitarian crises in Asia and Latin America, where many countries could not afford the more expensive mRNA vaccines that were being snapped up by rich western nations. It is estimated that it saved 6.3 million lives in 2021 alone.
Yet from the start the vaccine – created by research teams led by Professor Andy Pollard and Professor Sarah Gilbert at the Oxford Vaccine Centre – was dogged by controversy. It was linked to blood clots, US observers criticised protocols for its trials, and French president Emmanuel Macron claimed it was “quasi-ineffective” for people over 65. In fact, the vaccine is particularly effective for the elderly.


In very rare cases, the AZ vaccine can cause blood clots. According to the British Heart Foundation, one study in the BMJ showed that for every 10 million people vaccinated with AstraZeneca there would be a total of 73 extra cases of blood clots. By contrast 10 million Covid cases would trigger thousands of extra blood clot cases.
Many of the anxieties about the vaccine stemmed from national self-interests. However, others derive from the nature of vaccines themselves, and this raises issues that are likely to re-emerge with the arrival of any new pandemic in coming years, scientists have warned.
A vaccine is unlike any other type of medicine because it works by stimulating a person’s anti-pathogen defences, arming them in advance of a future infection. However, this preparation goes beyond helping one individual and can aid the general population, a point stressed by Professor Stephen Evans, of the London School of Medicine and Tropical Hygiene.
“If I take a preventative drug – such as a statin – then I am the only one who benefits,” said Evans. “However, there are people who cannot mount responses to a vaccine because they are ill or have a weakened immune system. They remain vulnerable. However, if you can build up herd immunity by ensuring the maximum number of people are inoculated, virus levels will drop and the vulnerable will be protected. If we believe we have responsibilities to help others, being vaccinated achieves that. There are moral concerns about being inoculated, in other words.”

Convincing the public – which has witnessed a rise in anti-vax propaganda in recent years – of this may not be easy. In addition, there is a second crucial difference between standard medical treatments and vaccines, added Professor Sir David Spiegelhalter, of the University of Cambridge. “We never know the identities of those who benefit [from a vaccine] – they are ‘statistical’ people – while those who are harmed can be named and their stories told.”
AstraZeneca’s Covid vaccine provides an example. We only know those who were harmed by it but cannot pinpoint those who benefited. Again, this makes it trickier to pinpoint a vaccine’s success and assure people of its efficacy. “To a certain extent, you can get round this and assess the impact of Covid vaccines by looking at the deaths of frontline workers in the health service during the pandemic’s early days,” added Evans. “Hundreds died, but if we had had a vaccine then it is now clear most would probably have survived.”
Most virologists and vaccine experts agree: when you look at the AstraZeneca vaccine from a global perspective, it probably benefited tens of millions of people, preventing deaths and reducing long-term consequences of Covid. It was a remarkable success, yet its passing has been marked by many who stressed its side-effects but never touched on its achievements.
“The paradox of vaccines is that people forget how important they are,” said Professor Adam Finn, of Bristol University. “They are like democracy. You enjoy it for a while and then forget how important it is to preserve it. It’s a problem.”
skip past newsletter promotion
Sign up to Observed

Free weekly newsletter
Analysis and opinion on the week's news and culture brought to you by the best Observer writers
Enter your email address
Sign up


Privacy Notice: Newsletters may contain info about charities, online ads, and content funded by outside parties. For more information see our Privacy Policy. We use Google reCaptcha to protect our website and the Google Privacy Policy and Terms of Service apply.
after newsletter promotion

AstraZeneca vaccines
AstraZeneca withdraws Covid-19 vaccine worldwide, citing surplus of newer vaccines
Read more

On the other hand, it is also clear politicians and officials will have to be careful about the claims they make, added Fiona Fox, head of the Science Media Centre. “Public trust in vaccines will come from open and honest communication. The benefits massively outweigh the risks as they did with this vaccine.
“But you won’t win any arguments by claiming that vaccines are 100% safe or running for the hills at the first reports of problems, which unfortunately too many government and NHS communications officers tend to do.
Downplaying risks is always tempting when you need people to take a mostly safe vaccine but it’s ultimately self-defeating because it erodes trust in the longer term.”
 

Users who are viewing this thread

Country Watch Latest

Back
Top